FDA delays Leqembi decision; Artiva raises $300M; Pharvaris prices offering
🗓️ FDA delays subcutaneous Leqembi decision: Originally slated for later this month, the decision date now falls on August 24, Biogen and Eisai said. The agency asked for more information from ...
May 8, 2026 11:09 AM EDT News Briefing FDA delays Leqembi decision; Artiva raises $300M on RA data; Pharvaris prices offering ENDPOINTS 🗓️ FDA delays subcutaneous Leqembi decision: Originally slated for later this month, the decision date now falls on August 24, Biogen and Eisai Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that